Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Ultragenyx Pharmaceutical Inc.

Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Present at Piper Sandler Healthcare Conference
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Announces Departure of Chief Financial Officer
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Present at Upcoming Healthcare Conferences
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Tickers RARE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.